ORCA-010, a Novel Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models

Improving the antitumor potency of current oncolytic adenoviruses represents one of the major challenges in development of these viruses for clinical use. We have generated an oncolytic adenovirus carrying the safety-enhancing E1AΔ24 deletion, the potency-enhancing T1 mutation, and the infectivity-e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dong, Wenliang, van Ginkel, Jan-Willem H., Au, Kam Y., Alemany, Ramon, Meulenberg, Janneke J.M., van Beusechem, Victor W.
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc. 2014
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4180126/
https://ncbi.nlm.nih.gov/pubmed/25093639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2013.229
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares